16 results on '"García Fernández FJ"'
Search Results
2. Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE)
- Author
-
García-Fernández FJ, Osca Asensi J, Romero R, Fernández Lozano I, Larrazabal JM, Martínez Ferrer J, Ortiz R, Pombo M, Tornés FJ, and Moradi Kolbolandi M
- Subjects
Implantable cardiac defibrillator, Pacemaker , Remote interrogation, Remote monitoring, Telemedicine - Abstract
This trial aimed to evaluate the safety and efficiency of a common and simplified protocol for the surveillance of cardiac implantable electronic devices based on remote monitoring (RM) in patients with pacemakers (PMs) and implantable cardiac defibrillators (ICDs) for at least 24 months.
- Published
- 2019
3. Arqueometría de ánforas prerromanas procedentes de lisboa (Portugal)
- Author
-
Martín-del-Río, JJ., Flores Alés, V., García Fernández, FJ., Filipe, V., Moreno Megías, V., and Fernandes, L.
- Abstract
En los últimos años se ha puesto de relieve la existencia de un denso tejido alfarero en el estuario del Tajo durante la Edad del Hierro, y en concreto en el área de Lisboa, que responde a un proceso de intensificación económica estimulado por la presencia de comerciantes fenicios. Uno de los productos más conspicuos son los envases anfóricos, recientemente identificados y clasificados a partir de los ejemplares registrados en distintas excavaciones arqueológicas. En los mismos contextos han aparecido también ánforas importadas procedentes en su mayoría del sur peninsular.
- Published
- 2021
- Full Text
- View/download PDF
4. A Bibliometric Evaluation of the Top 100 Cited Dimethyl Fumarate Articles
- Author
-
Ichiro Ikuta, Julián Solís García del Pozo, Alba Estela García-Fernández, Maria F. Galindo, Francisco Javier García-Fernández, Joaquín Jordán, Eduardo Nava, Institut Català de la Salut, García-Fernández FJ] Servicio de Análisis Clínicos, Hospital General de Tomelloso, Tomelloso, Spain. [García-Fernández AE] Servei de Bioquímica Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Ikuta I] Neuroradiology Section, Yale Center for Imaging Informatics, Department of Radiology & Biomedical Imaging, Yale University School of Medicine, New Haven, USA. [Nava E, Jordan J] Departamento de Ciencias Médicas, Facultad de Medicina de Albacete Universidad Castilla La Mancha, Albacete, Spain. [Solis García Del Pozo J] Departamento de Ciencias Médicas, Facultad de Medicina de Albacete Universidad Castilla La Mancha, Albacete, Spain. Servicio de Medicina Interna, Complejo Hospitalario Universitario de Albacete, Albacete, Spain, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
Research areas ,Bibliografia ,Pharmaceutical Science ,Library science ,Immunomodulatory drug ,Ciencias de la información::medios de comunicación::publicaciones::bibliografía como asunto::bibliometría [CIENCIA DE LA INFORMACIÓN] ,multiple sclerosis ,Original research ,Article ,bibliometric study ,Analytical Chemistry ,lcsh:QD241-441 ,03 medical and health sciences ,0302 clinical medicine ,lcsh:Organic chemistry ,Bibliometria ,Information Science::Communications Media::Publications::Bibliography as Topic::Bibliometrics [INFORMATION SCIENCE] ,Drug Discovery ,gestión de ciencia, tecnología e innovación en salud::comunicación y difusión científica::publicaciones científicas y técnicas [CIENCIA Y SALUD] ,Physical and Theoretical Chemistry ,030304 developmental biology ,0303 health sciences ,dimethyl fumarate ,compuestos orgánicos::ácidos carboxílicos::ácidos acíclicos::ácidos dicarboxílicos::fumaratos::dimetilfumarato [COMPUESTOS QUÍMICOS Y DROGAS] ,Organic Chemistry ,Publications ,Health Sciences, Technology, and Innovation Management::Scientific Communication and Diffusion::Scientific and Technical Publications [SCIENCE AND HEALTH] ,Authorship ,Audience measurement ,Tecfidera ,Ranking ,Chemistry (miscellaneous) ,Bibliometrics ,Molecular Medicine ,Medicaments immunosupressors ,Psychology ,Citation ,030217 neurology & neurosurgery ,Organic Chemicals::Carboxylic Acids::Acids, Acyclic::Dicarboxylic Acids::Fumarates::Dimethyl Fumarate [CHEMICALS AND DRUGS] - Abstract
Dimethyl fumarate is a cytoprotective and immunomodulatory drug used in the treatment of multiple sclerosis. We performed a bibliometric study examining the characteristics and trends of the top 100 cited articles that include dimethyl fumarate in the title. On 21 September 2020 we carried out an electronic search in the Web of Science (WOS), seeking articles that include the following terms within the title: dimethyl fumarate, BG-12, or Tecfidera. To focus our investigation on original research, we refined the search to include only articles, early access, others, case report, and clinical trials. We obtained a total of 1115 items, which were cited 7169 times, had a citation density of 6.43 citations/item, and an h-index of 40. Around 2010, there was a jump in the number of published articles per year, rising from 5 articles/year up to 12 articles/year. We sorted all the items by the number of citations and selected the top 100 most cited (T100). The T100 had 4164 citations, with a density of 37 citations/year and contained 16 classic research articles. They were published between 1961 and 2018, the years 2010–2018 amassed nearly 80% of the T100. We noted 17 research areas with articles in the T100. Of these, the number one ranking went to neurosciences/neurology with 39 articles, and chemistry ranked second on the T100 list with 14 items. We noticed that the percentage of articles belonging to different journals changed depending on the time period. Chemistry held the highest number of papers during 1961–2000, while pharmacology andneurosciences/neurology led the 2001–2018 interval. A total of 478 authors from 145 institutions and 25 countries were included in the T100 ranking. The paper by Gold R et al. was the most successful with 14 articles, 1.823 citations and a density of 140.23 citations/year. The biotechnological company Biogen led the T100 list with 20 articles. With 59 published articles, the USA was the leading country in publications. We concluded that this study analyzed the use of and research on dimethyl fumarate from a different perspective, which will allow the readership (expert or not) to understand the relevance of classic and recent literature on this topic.
- Published
- 2021
5. Percutaneous Gastrostomies: Associated Complications in PUSH vs. PULL Techniques over 12 Years in a Referral Centre.
- Author
-
Piñar-Gutiérrez A, González-Gracia L, Vázquez Gutiérrez R, García-Rey S, Jiménez-Sánchez A, González-Navarro I, Tatay-Domínguez D, Garrancho-Domínguez P, Remón-Ruiz PJ, Martínez-Ortega AJ, Serrano-Aguayo P, Giménez-Andreu MD, García-Fernández FJ, Bozada-García JM, Nacarino-Mejías V, López-Iglesias Á, Pereira-Cunill JL, and García-Luna PP
- Abstract
Objectives : To compare complications associated with percutaneous gastrostomies performed using PUSH and PULL techniques, whether endoscopic (PEG) or radiological (PRG), in a tertiary-level hospital. Methods : This was a prospective observational study. Adult patients who underwent percutaneous PULL or PUSH gastrostomy using PEG or PRG techniques at the Virgen del Rocio University Hospital and subsequently followed up in the Nutrition Unit between 2009-2020 were included. X2 tests or Fisher's test were used for the comparison of proportions when necessary. Univariate analysis was conducted to study risk factors for PRG-associated complications. Results : n = 423 (PULL = 181; PUSH = 242). The PULL technique was associated with a higher percentage of total complications (37.6% vs. 23.8%; p = 0.005), exudate (18.2% vs. 11.2%; p = 0.039), and irritation (3.3% vs. 0%; p = 0.006). In the total sample, there were 5 (1.1%) cases of peritonitis, 3 (0.7%) gastrocolic fistulas, and 1 (0.2%) death due to complications associated with gastrostomy. Gender, age, and different indications were not risk factors for a higher number of complications. The most common indications were neurological diseases (35.9%), head and neck cancer (29%), and amyotrophic lateral sclerosis (17.2%). Conclusions : The PULL technique was associated with more total complications than the PUSH technique, but both were shown to be safe techniques, as the majority of complications were minor.
- Published
- 2024
- Full Text
- View/download PDF
6. Gastrostomies: experience and complications with three modalities in a tertiary centre over a 26-year period.
- Author
-
Piñar-Gutiérrez A, Serrano-Aguayo P, Gutiérrez RV, Rey SG, González-Navarro I, Tatay-Domínguez D, Garrancho-Domínguez P, Remón-Ruiz PJ, Martínez-Ortega AJ, Mejías VN, Iglesias-López Á, Socas M, Morales-Conde S, García-Fernández FJ, Bozada-García JM, Pereira-Cunill JL, and García-Luna PP
- Abstract
Objectives: To describe the complications associated with the different gastrostomy techniques [endoscopic (PEG), radiologic (PRG), and surgical (SG)] performed in the last 26 years in a terciary hospital., Methods: Retrospective observational study. Patients who underwent gastrostomy at the Virgen del Rocío University Hospital between 1995 and 2021 were included. For PEG, the PULL technique was performed until 2018 and subsequently the PUSH technique predominantly. For PRG, a pigtail catheter was used until 2003, a balloon catheter between 2003 and 2009, and a balloon catheter with gastropexy between 2015 and 2021. For SG, the conventional technique (CSG) was performed until 2009 and since then the laparoscopic assisted percutaneous gastrostomy (PLAG) technique. Descriptive analysis was performed obtaining the median and quartiles of the quantitative variables [P50 (P25-P75)] and the frequency for the qualitative variables [ n (%)].The comparison of complications between patients who underwent different techniques was performed with Fisher's test., Results: n = 1,070 (PEG = 608, PRG = 344, SG = 118). The three most frequent indications were head and neck tumors, neurological diseases and gastroesophageal tumors. The percentage of patients who had any complication was 48.9% (PEG-PULL), 23.7% (PEG-PUSH), 38.5% (pigtail PRG), 39.2% (balloon PRG), 29.7% (balloon with gastropexy PRG), 87.3% (CSG), and 41.26% (PLAG). 2 (0.18%) patients died from gastrostomy-related complications. 18(1.68%) presented with peritonitis and 5 (0.4%) presented with gastrocolic fistula. The rest of the complications were minor., Conclusion: Gastrostomy in any of its modalities is currently a safe procedure with a low rate of complications, most of which are minor., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Piñar-Gutiérrez, Serrano-Aguayo, Gutiérrez, Rey, González-Navarro, Tatay-Domínguez, Garrancho-Domínguez, Remón-Ruiz, Martínez-Ortega, Mejías, Iglesias-López, Socas, Morales-Conde, García-Fernández, Bozada-García, Pereira-Cunill and García-Luna.)
- Published
- 2023
- Full Text
- View/download PDF
7. Time-Tested Strategies in Modern Context: A Bibliometric Study of Chemotherapy's Continued Importance in Colorectal Cancer Treatment.
- Author
-
Clar-Marmaneu H, García-Fernández AE, and García-Fernández FJ
- Abstract
In the landscape of colorectal cancer treatment, classical chemotherapeutic agents such as 5-fluorouracil, capecitabine, irinotecan, oxaliplatin, trifluridine, and tipiracil have historically played a pivotal role. This study presents a comprehensive bibliometric analysis of the top 100 most influential articles focusing on these classic chemotherapy drugs in the management of colorectal cancer. With this, we shed light on their current importance, despite the emergence of new therapeutic targets and treatments in the field of oncology. Systematically evaluating research outputs, this analysis reveals a prevalence of co-authorship among institutions, countries (led by the United States, China, and Europe), and researchers highlighting the global and collaborative nature of efforts in research, utilization, and development of these drugs. Three thematic axes lead the research: pharmacogenetics, the development of new pharmaceutical forms, and the use of adjuvants. This research serves as a foundation for future endeavors, aiding researchers, clinicians, and policymakers in making informed decisions about the direction of research and development in the dynamic field of colorectal cancer therapy.
- Published
- 2023
- Full Text
- View/download PDF
8. Multitraction with rubber bands and surgical silk as a method to facilitate endoscopic submucosal dissection.
- Author
-
Martín Guerrero JM, Moreno Loro A, García Fernández FJ, Rincón Gatica A, and Bozada García JM
- Subjects
- Humans, Treatment Outcome, Dissection methods, Mucous Membrane, Surgical Instruments, Endoscopic Mucosal Resection methods
- Abstract
We propose this variant of the clip technique as a method that assist traction during endoscopic submucosal dissection (ESD): traction on the mucosa plane using an hemoclip carrying a surgical silk and three rubber bands, before the incision, to allow easier access to the submucosa space. We propose this variant with the intention of facilitating access to ESD quickly and safely for beginners.
- Published
- 2023
- Full Text
- View/download PDF
9. [Early remote monitoring of pacemaker devices and benefits of this paradigm shift. The FAST REMOTE study].
- Author
-
Valverde André I, González Vasserot M, Gonzalez Chana B, González Matos C, Villagraz Tecedor L, and García Fernández FJ
- Published
- 2023
- Full Text
- View/download PDF
10. A Bibliometric Evaluation of the Top 100 Cited Dimethyl Fumarate Articles.
- Author
-
García-Fernández FJ, García-Fernández AE, Ikuta I, Nava E, Solis García Del Pozo J, Jordan J, and Galindo MF
- Subjects
- Authorship, Bibliometrics, Dimethyl Fumarate chemistry, Publications
- Abstract
Dimethyl fumarate is a cytoprotective and immunomodulatory drug used in the treatment of multiple sclerosis. We performed a bibliometric study examining the characteristics and trends of the top 100 cited articles that include dimethyl fumarate in the title. On 21 September 2020 we carried out an electronic search in the Web of Science (WOS), seeking articles that include the following terms within the title: dimethyl fumarate, BG-12, or Tecfidera. To focus our investigation on original research, we refined the search to include only articles, early access, others, case report, and clinical trials. We obtained a total of 1115 items, which were cited 7169 times, had a citation density of 6.43 citations/item, and an h-index of 40. Around 2010, there was a jump in the number of published articles per year, rising from 5 articles/year up to 12 articles/year. We sorted all the items by the number of citations and selected the top 100 most cited (T100). The T100 had 4164 citations, with a density of 37 citations/year and contained 16 classic research articles. They were published between 1961 and 2018; the years 2010-2018 amassed nearly 80% of the T100. We noted 17 research areas with articles in the T100. Of these, the number one ranking went to neurosciences/neurology with 39 articles, and chemistry ranked second on the T100 list with 14 items. We noticed that the percentage of articles belonging to different journals changed depending on the time period. Chemistry held the highest number of papers during 1961-2000, while pharmacology andneurosciences/neurology led the 2001-2018 interval. A total of 478 authors from 145 institutions and 25 countries were included in the T100 ranking. The paper by Gold R et al. was the most successful with 14 articles, 1.823 citations and a density of 140.23 citations/year. The biotechnological company Biogen led the T100 list with 20 articles. With 59 published articles, the USA was the leading country in publications. We concluded that this study analyzed the use of and research on dimethyl fumarate from a different perspective, which will allow the readership (expert or not) to understand the relevance of classic and recent literature on this topic.
- Published
- 2021
- Full Text
- View/download PDF
11. Caustic esophageal injury by impaction of cell batteries.
- Author
-
García Fernández FJ, León Montañés R, and Bozada Garcia JM
- Subjects
- Adult, Burns, Chemical diagnostic imaging, Electric Power Supplies, Endoscopy, Gastrointestinal, Esophagus diagnostic imaging, Esophagus pathology, Female, Foreign Bodies, Humans, Mucous Membrane pathology, Ulcer pathology, Burns, Chemical pathology, Esophagus injuries, Suicide, Attempted
- Abstract
The ingestion of cell batteries can cause serious complications (fistula, perforation or stenosis) at the esophageal level. The damage starts soon after ingestion (approximately 2 hours) and is directly related to the amount of time the battery is lodged in said location, the amount of electrical charge remaining in the battery, and the size of the battery itself. Injury is produced by the combination of electrochemical and chemical mechanisms and pressure necrosis. The ingestion of multiple cells and a size > = 20 mm are related with more severe and clinically significant outcomes. A female patient, 39 years old, with a history of previous suicide attempts, was admitted to the Emergency Room with chest pain and dysphagia after voluntary ingestion of 2 cell batteries. Two cell batteries are easily detected in a routine chest X-ray, presenting a characteristic double-ring shadow, or peripheral halo. Urgent oral endoscopy was performed 10 hours after ingestion, showing a greenish-gray lumpy magma-like consistency due to leakage of battery contents. The 2 batteries were sequentially removed with alligator-jaw forceps. After flushing and aspiration of the chemical material, a broad and circumferential injury with denudation of the mucosa and two deep ulcerations with necrosis were observed where the batteries had been. The batteries' seals were eroded, releasing chemical contents. Despite the severity of the injuries, the patient progressed favorably and there was no esophageal perforation. Esophageal impaction of cell batteries should always be considered an endoscopic urgency.
- Published
- 2016
12. Differential Responses of the Septal Ventricle and the Atrial Signals During Ongoing Entrainment: A Method to Differentiate Orthodromic Reciprocating Tachycardia Using Septal Accessory Pathways From Atypical Atrioventricular Nodal Reentry.
- Author
-
Calvo D, Ávila P, García-Fernández FJ, Pachón M, Bravo L, Eidelman G, Hernández J, Miracle ÁL, Rubín J, Pérez D, Arenal Á, Atienza F, Jimenez-Candil J, Arias MÁ, Datino T, Martínez-Camblor P, Gonzalez-Torrecilla E, and Almendral J
- Subjects
- Cardiac Pacing, Artificial, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Sensitivity and Specificity, Tachycardia, Atrioventricular Nodal Reentry physiopathology, Tachycardia, Reciprocating physiopathology, Accessory Atrioventricular Bundle physiopathology, Electrophysiologic Techniques, Cardiac, Heart Conduction System physiopathology, Tachycardia, Atrioventricular Nodal Reentry diagnosis, Tachycardia, Reciprocating diagnosis
- Abstract
Background: Differential diagnosis between tachycardia mediated by septal accessory pathways (AP) and atypical atrioventricular nodal reentry can be challenging. We hypothesized that an immediate versus delayed pace-related advancement of the atrial electrogram, once the local septal parahisian ventricular electrogram (SVE) has been advanced, may help in this diagnosis., Methods and Results: We focused on differential timing between SVE and atrial signals at the initiation of continuous right ventricular apical pacing during tachycardia. SVE advancement preceding atrial reset was defined as SVE advanced by the paced wave fronts while atrial signal continued at the tachycardia cycle. We analyzed 51 atypical atrioventricular nodal reentry (45% posterior type) and 80 AP tachycardias (anteroseptal [10], parahisian [18], midseptal [12], and posteroseptal [40]). SVE advancement preceding atrial reset was observed in 98% of atrioventricular nodal reentries during 4±1.1 cycles; this phenomena was observed in 6 (8%) of the atrioventricular reentrant tachycardia mediated by septal AP (P<0.001; sensitivity 98%; specificity 93%; positive predictive value 90%; negative predictive value 99%) and lasted 1 single cycle (P<0.001). Right posteroseptal AP tachycardias were distinctly characterized by atrial reset preceding SVE advancement (with ventricular fusion; specificity 100%; positive predictive value 100%). In 11 cases, it was impossible to achieve sustain entrainment. In all of them, the differential responses at the entrainment attempt allowed for appropriate diagnosis., Conclusions: The differential response of the SVE and the atrial electrogram at the initiation of continuous right ventricular apical pacing during tachycardia effectively distinguishes between atypical atrioventricular nodal reentry and atrioventricular reentrant tachycardia mediated by septal APs., (© 2015 American Heart Association, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
13. Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients.
- Author
-
González-Lama Y, Bermejo F, López-Sanromán A, García-Sánchez V, Esteve M, Cabriada JL, McNicholl AG, Pajares R, Casellas F, Merino O, Carpio D, Vera MI, Muñoz C, Calvo M, Benito LM, Bujanda L, García-Fernández FJ, Ricart E, Ginard D, Velasco M, Carneros JA, Manceñido N, Calvo M, Algaba A, Froilan C, Cara C, Maté J, Abreu L, and Gisbert JP
- Subjects
- Adolescent, Adult, Aged, Area Under Curve, Biomarkers metabolism, Dose-Response Relationship, Drug, Female, Guanine Nucleotides blood, Humans, Inflammatory Bowel Diseases enzymology, Male, Middle Aged, Prospective Studies, ROC Curve, Thionucleotides blood, Treatment Outcome, Young Adult, Azathioprine blood, Immunosuppressive Agents therapeutic use, Inflammatory Bowel Diseases drug therapy, Mercaptopurine administration & dosage, Mercaptopurine analogs & derivatives, Methyltransferases blood
- Abstract
Background: Low thiopurine-methyl-transferase (TPMT) activity and high 6-thioguanine-nucleotide (6TGN) concentrations have been linked to therapeutic success in inflammatory bowel disease patients treated with thiopurines; however, this has not been implemented in clinical practice., Aim: To identify a therapeutic threshold value for TPMT or 6TGN concentrations, and their capability to predict treatment safety and efficacy., Methods: Prospective multicentre study including steroid-resistant/dependent patients starting thiopurines. The TPMT activity was determined at inclusion (>5 U/mL required). Azathioprine metabolites [6TGN, 6-methyl-mercaptopurine ribonucleotides (6MMP), and 6TGN/6MMP and 6TGN/TPMT ratios] were periodically monitored during steroid tapering and after withdrawal for 6 months or until a new flare occurred., Results: A total of 113 patients were analysed (62% clinical response). Areas under the receiver operating characteristic (ROC) curve (AUC) relating clinical response and metabolite levels at 2, 4 and 6 months after steroid withdrawal were less than 0.7. The AUCs relating final response and initial TPMT activity or metabolite concentrations at 2, 4, 8 and 16 weeks after starting thiopurines were less than 0.7. No cut-off point with worthwhile sensitivity/specificity was found. Eight (7%) patients developed thiopurine-related toxicity that could not be linked to TPMT activity or 6TGN levels., Conclusions: Our results do not support determination of TPMT activity or 6TGN concentrations to predict treatment outcome, and no useful serum metabolites threshold value to adjust the drug's dose was identified., (© 2011 Blackwell Publishing Ltd.)
- Published
- 2011
- Full Text
- View/download PDF
14. [Sprint fidelis defibrillation lead: a nine-center experience in Spain].
- Author
-
Arias MA, Domínguez-Pérez L, Toquero J, Jiménez-Candil J, Olagüe J, Díaz-Infante E, Tercedor L, Valverde I, Castro J, García-Fernández FJ, and Rodríguez-Padial L
- Subjects
- Adolescent, Aged, Aged, 80 and over, Equipment Failure, Female, Follow-Up Studies, Heart Diseases complications, Heart Diseases therapy, Humans, Male, Middle Aged, Spain, Stroke Volume physiology, Defibrillators, Implantable, Electric Countershock instrumentation
- Abstract
Introduction and Objectives: Sprint Fidelis defibrillation leads are prone to early failure. Most of the reported series come from a single institution. This paper describes the clinical experience in nine Spanish hospitals., Methods: Clinical, implant, and follow-up data of all patients with a Sprint Fidelis lead were analyzed. All cases of lead failure were identified, medium-term lead survival was calculated, and possible predictors for lead failure were determined., Results: In total, 378 leads in 376 patients were studied. The mean age (male 85.7%) was 64.9 ± 13.6 years. The majority of patients (59.8%) had ischemic heart disease. Mean left ventricular ejection fraction was 33.4% ± 14.5%. Left subclavian vein puncture was used in 74.8%. During a mean follow-up of 30.9 ± 14 months, 16 lead failures have occurred, with a lead survival of 96.1% at 36 months after implantation. Eleven of 16 lead failures were caused by failure of pace/sense conductors, 3 by defects in the high-voltage conductor, and 2 by defects in both types of conductors. A less depressed left ventricular ejection fraction was associated with an increased probability of lead failure (42.4% ± 16% vs. 33% ± 14.3%; P =.011). Three hospitals presented a rate of lead failure higher than 10%; the rate was less than 5% in the remaining 6 hospitals., Conclusions: In this multicenter series of 378 leads, the 3-year estimated survival was higher than that reported in prior series. Clinical presentation of lead failures was similar to that reported previously. Left ventricular ejection fraction and hospital of implantation were variables associated to lead failure., (Copyright © 2010 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
15. Rate-related changes in QRS morphology in patients with fixed bundle branch block: implications for differential diagnosis of wide QRS complex tachycardia.
- Author
-
Datino T, Almendral J, González-Torrecilla E, Atienza F, García-Fernández FJ, Arenal A, Atea L, and Fernández-Avilés F
- Subjects
- Aged, Bundle-Branch Block physiopathology, Diagnosis, Differential, Electrocardiography methods, Female, Heart Function Tests, Heart Rate physiology, Humans, Male, Middle Aged, Prospective Studies, Tachycardia, Supraventricular physiopathology, Tachycardia, Ventricular physiopathology, Bundle-Branch Block diagnosis, Tachycardia, Supraventricular diagnosis, Tachycardia, Ventricular diagnosis
- Abstract
Aims: To analyse QRS morphology in response to rapid atrial pacing (RAP) and supraventricular tachycardia (SVT) in patients with pre-existing bundle branch block (BBB)., Methods and Results: We prospectively studied 59 patients in sinus rhythm (SR), with QRS > or = 120 ms, and no pre-excitation. Trains of RAP were introduced at increasing rates until atrioventricular block. QRS during SR and last QRS complex of each RAP train were compared on the 12-leads. Previously described criteria for minor and major configuration differences were used to identify QRS changes. During RAP minor QRS changes were seen in 22 (37%) and major changes in 23 (39%) subjects. One patient showed major axis shifts and no one showed a change to the contralateral BBB pattern. QRS changes were significantly and independently related to RAP rate and type of BBB (more frequent if right-BBB). Of 14 subjects (24%) with SVT, 13 displayed the same QRS changes during RAP., Conclusion: In patients with organic BBB, important changes in QRS morphology, except for a change in the contralateral BBB, can appear during RAP and SVT. Thus, in these patients, a change in QRS morphology during tachycardia does not necessarily imply that it is ventricular tachycardia.
- Published
- 2008
- Full Text
- View/download PDF
16. [Intramyocardial dissecting haematoma: an unusual form of cardiac rupture].
- Author
-
García Fernández FJ, Carmona JR, Lezaun R, Ruiz Quevedo V, Beloqui R, and De los Arcos E
- Subjects
- Aged, Electrocardiography, Fatal Outcome, Heart Rupture, Post-Infarction diagnosis, Heart Rupture, Post-Infarction therapy, Humans, Male, Heart Rupture, Post-Infarction pathology, Heart Ventricles pathology
- Abstract
The intramyocardial dissecting haematoma is an unusual rupture of the left ventricular wall, complicating acute myocardial infarction. The mechanism is an hemorrhagic dissection among the spiral myocardial fibres creating a neocavitation limited by the myocardium. It appears in 9% of left ventricular wall ruptures, complicating acute myocardial infarction. Diagnosis is often difficult and in most of the cases it is post-mortem. We present the case report of a 69 year old patient who suffered a posterolateral acute myocardial infarction treated with primary PTCA/Stent plus AAS, clopidogrel, unfractioned heparin bolus and GP IIb- IIIa inhibitors. In the following few hours he suffered this unusual form of cardiac rupture that took him into cardiogenic shock and finally led to his death. The pathophysiology, diagnosis and management of this lethal complication of acute myocardial infarction (90% mortality in the medically treated group) which is only effectively treated by surgery are also reviewed.
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.